Picard Medical stock experienced a significant drop of approximately 65% in premarket trading on Friday, falling from its recent 52-week high of $13.36.
The crash erased months of upward price momentum, during which the stock traded 131.6% above its 50-day Simple Moving Average.
The plan signals substantial future dilution that will devalue existing shareholder equity.
The stock plunge contradicts Picard Medical's recent positive updates on its core technology.
Author's summary: Picard Medical stock drops 65% due to equity plan expansion.